CpG-ODN-based immunotherapy is effective in controlling the growth of metastasized tumor cells

Cancer Letters

Volumn 274, Issue 1, 2009, Pages 160-164

  Kim, Han A ^a   Ko, Hyun Mi ^a,b   Ju, Hye Won ^a   Kim, Kyoung Jin ^a   Roh, Si Gyun ^c   Lee, Hern Ku ^b   Im, Suhn Young ^a  

^a Chonnam National University   (South Korea)

^b Chonbuk National University   (South Korea)

^c Chonbuk National University Medical School   (South Korea)

Author keywords

CpG ODN; Tumor metastasis

Indexed keywords

CPG OLIGODEOXYNUCLEOTIDE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CANCER CELL; CANCER CONTROL; CANCER IMMUNOTHERAPY; COLON CANCER; DRUG EFFICACY; DRUG INHIBITION; FEMALE; GROWTH INHIBITION; LUNG METASTASIS; MELANOMA CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; TUMOR CELL;

ANIMALS; COLONIC NEOPLASMS; CPG ISLANDS; FEMALE; IMMUNOTHERAPY; INJECTIONS, SUBCUTANEOUS; LUNG NEOPLASMS; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; OLIGODEOXYRIBONUCLEOTIDES; SURVIVAL RATE; TUMOR CELLS, CULTURED;

MURINAE;

EID: 57749117219     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2008.09.014     Document Type: Article

References (24)

1. Fidler I.J., and Balch C.M. The biology of cancer metastasis and implications for therapy. Curr. Probl. Surg. 24 (1987) 129-209
2. Sugarbaker E.V. Cancer metastasis: a product of tumor-host interactions. Curr. Probl. Surg. 3 (1979) 1-59
3. Fidler I.J., and Hart I.R. Biological diversity in metastatic neoplasms: origins and implications. Science 217 (1982) 998-1003
4. Poste G., and Fidler I.J. The pathogenesis of cancer metastasis. Nature 283 (1980) 139-146
5. Tokunaga T., Yamamoto H., Shimada S., Abe H., Fukuda T., Fujisawa T., Furutani Y., Yano O., Kataoka T., Sudo T., et al. Antitumor activity of deoxyribonucleic acid fraction from Mycobacterium bovis BCG. I. Isolation, physicochemical characterization, and antitumor activity. J. Natl. Cancer Inst. 72 (1984) 955-962
6. Krieg A.M., Yi A.K., Matson S., Waldschmidt T.J., Bishop G.A., Teasdale R., Koretzky G.A., and Klinman D.M. CpG motifs in bacterial DNA trigger direct B-cell activation. Nature 374 (1995) 546-549
7. Hemmi H., Takeuchi O., Kawai T., Kaisho T., Sato S., Sanjo H., Matsumoto M., Hoshino K., Wagner H., Takeda K., and Akira S. A toll-like receptor recognizes bacterial DNA. Nature 408 (2000) 740-745
8. Chu R.S., Targoni O.S., Krieg A.M., Lehmann P.V., and Harding C.V. CpG oligodeoxynucleotides act as adjuvants that switch on T helper 1 (Th1) immunity. J. Exp. Med. 186 (1997) 1623-1631
9. Shirota H., Sano K., Hirasawa N., Terui T., Ohuchi K., Hattori T., Shirato K., and Tamura G. Novel roles of CpG oligodeoxynucleotides as a leader for the sampling and presentation of CpG-tagged antigen by dendritic cells. J. Immunol. 167 (2001) 66-74
10. Vabulas R.M., Pircher H., Lipford G.B., Häcker H., and Wagner H. CpG-DNA activates in vivo T cell epitope presenting dendritic cells to trigger protective antiviral cytotoxic T cell responses. J. Immunol. 164 (2000) 2372-2378
11. Jakob T., Walker P.S., Krieg A.M., Udey M.C., and Vogel J.C. Activation of cutaneous dendritic cells by CpG-containing oligodeoxynucleotides: a role for dendritic cells in the augmentation of Th1 responses by immunostimulatory DNA. J. Immunol. 161 (1998) 3042-3049
12. Sparwasser T., Koch E.S., Vabulas R.M., Heeg K., Lipford G.B., Ellwart J.W., and Wagner H. Bacterial DNA and immunostimulatory CpG oligonucleotides trigger maturation and activation of murine dendritic cells. Eur. J. Immunol. 28 (1998) 2045-2054
13. Hartmann G., Weiner G.J., and Krieg A.M. CpG DNA: a potent signal for growth, activation, and maturation of human dendritic cells. Proc. Natl. Acad. Sci. USA 96 (1999) 9305-9310
14. Blazar B.R., Krieg A.M., and Taylor P.A. Synthetic unmethylated cytosine-phosphate-guanosine oligodeoxynucleotides are potent stimulators of antileukemia responses in naïve and bone marrow transplant (BMT) recipients. Blood 98 (2001) 1217-1225
15. Ballas Z.K., Krieg A.M., Warren T., Rasmussen W., Davis H.L., Waldschmidt M., and Weiner G.J. Divergent therapeutic and immunologic effects of oligodeoxynucleotides with distinct CpG motifs. J. Immunol. 167 (2001) 4878-4886
16. Carpentier A.F., Chen L., Maltonti F., and Delattre J.Y. Oligodeoxynucleotides containing CpG motifs can induce rejection of a neuroblastoma in mice. Cancer Res. 59 (1999) 5429-5432
17. Carpentier A.F., Xie J., Mokhtari K., and Delattre J.Y. Successful treatment of intracranial gliomas in rat by oligodeoxynucleotides containing CpG motifs. Clin. Cancer Res. 6 (2000) 2469-2473
18. + T cell-mediated eradication of established tumors by peritumoral injection of CpG-containing oligodeoxynucleotides. J. Immunol. 167 (2001) 5247-5253
19. Heckelsmiller K., Rall K., Beck S., Schlamp A., Seiderer J., Jahrsdörfer B., Krug A., Rothenfusser S., Endres S., and Hartmann G. Peritumoral CpG DNA elicits a coordinated response of CD8 T cells and innate effectors to cure established tumors in a murine colon carcinoma model. J. Immunol. 169 (2002) 3892-3899
20. Hafner M., Zawatzky R., Hirtreiter C., Buurman W.A., Echtenacher B., Hehlgans T., and Männel D.N. Antimetastatic effect of CpG DNA mediated by type I IFN. Cancer Res. 61 (2001) 5523-5528
21. Whitmore M.M., Li S., Falo Jr. L., and Huang L. Systemic administration of LPD prepared with CpG oligonucleotides inhibits the growth of established pulmonary metastases by stimulating innate and acquired antitumor immune responses. Cancer Immunol. Immunother. 50 (2001) 503-514
22. Kunikata N., Sano K., Honda M., Ishii K., Matsunaga J., Okuyama R., Takahashi K., Watanabe H., Tamura G., Tagami H., and Terui T. Peritumoral CpG oligodeoxynucleotide treatment inhibits tumor growth and metastasis of B16F10 melanoma cells. J. Invest. Dermatol. 123 (2004) 395-402
23. Weigel B.J., Rodeberg D.A., Krieg A.M., and Blazar B.R. CpG oligodeoxynucleotides potentiate the antitumor effects of chemotherapy or tumor resection in an orthotopic murine model of rhabdomyosarcoma. Clin. Cancer Res. 9 (2003) 3105-3114
24. Torosian M.H., and Donoway R.B. Growth hormone inhibits tumor metastasis. Cancer 67 (1991) 2280-2283